The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer-Reference-Cited by-同舟云学术

The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer

Published:2024-01 Issue: Volume: Page:
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Tang Hao-Yu,Cao Yi-Zhi,Zhou Yi-Wei,Ma Yu-Shui,Jiang Hong,Zhang Hui,Jiang Lin,Yang Qin-Xin,Tang Xiao-Mei,Yang Chun,Liu Xin-Yun,Liu Fu-Xing,Liu Ji-Bin,Fu Da,Wang Yun-Feng,Yu Hong

Publisher

Elsevier BV

Reference111 articles.

1. T-cell therapy for lymphoma using nonengineered multiantigen-targeted T cells is safe and produces durable clinical effects;Vasileiou;J Clin Oncol,2021

2. Chimeric antigen receptor T-cell therapy in multiple myeloma: a comprehensive review of current data and implications for clinical practice;Parikh;CA Cancer J Clin,2023

3. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study;Granit;Lancet Neurol,2023

4. TCR-engineered T cell therapy in solid tumors: state of the art and perspectives;Baulu;Sci Adv,2023

5. 'Off-the-shelf' allogeneic CAR T cells: development and challenges;Depil;Nat Rev Drug Discov,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor-T cells targeting epithelial cell adhesion molecule antigens are effective in the treatment of colorectal cancer;BMC Gastroenterology;2024-08-06

2. Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications;International Journal of Nanomedicine;2024-07

3. Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigens;Cellular Immunology;2024-05

4. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection;Cancer Treatment Reviews;2024-04

5. Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data;Diagnostics;2024-03-21